Highbridge Capital Management’s Aegerion Pharmaceuticals AEGR Stock Holding History

Highbridge Capital Management’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-23,500	Closed	-$785K	–	1592
2014 Q3	$785K	Buy	23,500 +14,600	+164%	+$453K	0.01%	739
2014 Q2	$286K	Buy	+8,900	New	+$331K	﹤0.01%	885

Highbridge Capital Management's AEGR Position: Q2 2016 in Review

Highbridge Capital Management sold out of Aegerion Pharmaceuticals (AEGR) in Q2 2016, closing a stake of 81,135 shares — an estimated $186K sold.

Highbridge Capital Management first reported a position in AEGR in Q2 2013 and held it in 4 quarters. The position peaked at $8M in Q3 2013. 71 funds tracked by Wall St. Rank hold AEGR as of Q2 2016.

Highbridge Capital Management reported no remaining Aegerion Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
Highbridge Capital Management sold 81,135 Aegerion Pharmaceuticals shares in Q2 2016, an estimated $186K.
Highbridge Capital Management first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 4 quarters.
Highbridge Capital Management's Aegerion Pharmaceuticals position peaked at $8M in Q3 2013.
71 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2016.

Based on Highbridge Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.